The KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease recommend initial antihypertensive therapy with an ACE inhibitor or an Angiotensin Receptor Blocker (ARB) for patients with CKD, regardless of ethnicity recognizing that many will require combination therapy with a diuretic [38]. Here, ACE is linked to chronic kidney disease.